Back Pain Doctor
Rheumatoid Arthritis
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Rheumatoid arthritis is a chronic autoimmune disease in which the immune system attacks the joint lining, causing pain, stiffness and swelling: most often starting in the small joints of the hands and feet and typically affecting both sides of the body. Left untreated it can damage cartilage, bone and tendons, though modern treatment now frequently prevents this.
Recognising it early is the priority. Persistent swelling of small joints with prolonged morning stiffness for six weeks or more warrants assessment, including blood tests and prompt rheumatology referral. This is an inflammatory condition distinct from wear-related osteoarthritis, and the management is very different.
Care is shared. A rheumatologist directs disease-modifying treatment (including conventional and biologic DMARDs and newer targeted agents, available in Australia through the PBS under set criteria), while the GP supports ongoing monitoring, immunisation, heart and bone health, and general wellbeing. Anti-inflammatory medication and short courses of corticosteroids can relieve symptoms but do not replace disease-modifying treatment.
Common symptoms
- Pain, swelling and stiffness in several joints, often on both sides of the body
- Prolonged early-morning stiffness lasting more than 30 to 60 minutes
- Small joints of the hands and feet often affected first
- Fatigue and feeling generally unwell
Evidence for twelve treatment options in rheumatoid arthritis
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Exercise and education sit alongside disease-modifying medication, not instead of it. The American College of Rheumatology's guideline for rheumatoid arthritis gives consistent exercise its one strong recommendation, alongside conditional recommendations for rehabilitation such as hand therapy, splinting and foot orthoses (England, Arthritis Care Res 2023), and the EULAR recommendations, updated in 2025, make physical activity part of standard care throughout the course of inflammatory arthritis (Rausch Osthoff, Ann Rheum Dis 2026). Across 13 randomised trials (967 people) aerobic exercise improved function and reduced pain by a moderate amount (pain standardised mean difference -0.46; Ye, BMC Sports Sci Med Rehabil 2022), and a 2026 analysis of 44 trials (3,132 people) found resistance training reduced pain by about 14 points out of 100 at the best-performing dose, with confidence in the evidence rated very low to moderate (Huo, Semin Arthritis Rheum 2026). The largest single trial randomised 490 people with painful rheumatoid hands to a tailored hand exercise program or usual care: hand function was better at 12 months (4.3 points on the Michigan Hand Outcomes Questionnaire, 95% CI 1.5 to 7.1), but pain did not differ, and there were no serious adverse events (Lamb, Lancet 2015). What exercise does not reliably do is lower disease activity: the pooled effect on inflammation measures is small or absent (Brady, BMC Rheumatol 2023; Courel-Ibáñez, Ann Phys Rehabil Med 2026), which is why it is paired with medical treatment rather than offered as a substitute.
Pairing reviewed 2026-11-05.
Where it fits
The critical point is sequencing: this does not replace rheumatological treatment, and a delay in getting disease control is the thing that causes lasting damage. Assessment here is aimed at recognising the pattern early and getting you to the right treatment, with exercise supporting it throughout.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Trigger-point injection reviews address confirmed myofascial pain and find heterogeneous, generally low-certainty results; they do not establish the technique as treatment for the underlying diagnosis. Condition reviewed: rheumatoid arthritis.
Evidence source: Debrosse et al., trigger-point injection systematic review (2022)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis, this may be considered only when examination finds a separate tender muscle band reproducing part of the pain. It does not treat the primary pathology and is used to help movement or rehabilitation.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. Good support
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
Injecting an inflamed rheumatoid joint has trial evidence behind it. In a double-blind trial of 60 people with rheumatoid arthritis and an inflamed knee, triamcinolone injected into the joint relieved pain, swelling and morning stiffness better than the same dose given into muscle (Konai, Clin Exp Rheumatol 2009). In 160 people with early rheumatoid arthritis treated to target with methotrexate, 1,373 joints were injected with betamethasone: about six in ten people had a good overall response by six weeks, and 62.3% of the joints injected at the start had not flared again at one year and 55.5% at two years, with second and third injections into the same joint lasting less well than the first (Hetland, Ann Rheum Dis 2012). Ultrasound earns its place mainly in choosing the joint. In a randomised trial of ultrasound-informed care, injecting a swollen joint that showed no Doppler signal of active inflammation was no better than leaving it alone, while joints with moderate Doppler activity responded best (Nordberg, Arthritis Rheumatol 2018). Whether it also helps place the needle is disputed: that same analysis found guided injection no more successful than injection by feel, while a randomised trial of 244 inflamed joints, three-quarters of them rheumatoid, found guidance gave 81% less injection pain, 38% more responders and a 32% longer-lasting effect (Sibbitt, J Rheumatol 2011).
Pairing reviewed 2026-10-02.
Where it fits
For one or two joints that stay inflamed despite your regular treatment, or during a flare. Coordinated with your rheumatologist and your systemic treatment, not instead of it. A joint that keeps needing injections is a signal to review that treatment.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Not offered for this
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
Not appropriate over a systemic inflammatory process, healing bone, an area of osteonecrosis or a complete tendon or ligament rupture.
Pairing reviewed 2026-08-30.
Where it fits
Not offered for this.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. One case series of 15
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched 27 October 2026 (the rheumatoid searches named in the focused row, plus radial device terms with arthralgia, inflammatory joint disease and spondyloarthritis: 1 record). In a series of 15 people with persisting joint pain after more than three months of disease-modifying drugs, three months of radial shockwave lowered pain on movement from 5.7 to 2.2 out of 10 and shortened morning stiffness, and 11 stopped their pain-relief medicine; there was no comparison group, and blood markers of inflammation did not change (Liu, Pain Pract 2018). No randomised trial of a radial device in rheumatoid arthritis was found; the one trial used a focused device (Zhang, Pain Res Manag 2024).
Pairing reviewed 2026-10-27.
Where it fits
Never a substitute for your rheumatologist's treatment. Discussed for joint or soft-tissue pain that persists once the disease is controlled, alongside the exercise program.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. One small trial, two weeks
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched 27 October 2026: shockwave, shock wave, ESWT or pressure wave with rheumatoid or inflammatory arthritis (8 records, all read), with a trial and review pass (3). The old line here said shockwave has no role; that does not survive the search. In one randomised trial of 40 people with rheumatoid arthritis and painful wrists or knees, all already treated with disease-modifying drugs, focused (piezoelectric) shockwave around the painful joint lowered pain from 4.9 to 1.2 out of 10 over 14 days, against 4.8 to 2.6 in a group given diclofenac and methotrexate; no adverse events were reported (Zhang, Pain Res Manag 2024). That trial was small, allocated by alternating numbers, used an unusual comparison and stopped at two weeks. A meta-analysis of pain treatments in rheumatoid arthritis found shockwave reduced pain by about 3.4 points out of 10, but pooled change from baseline in small studies with high heterogeneity and publication bias (Lautenschlager, Adv Rheumatol 2025). Nothing shows that shockwave changes the disease.
Pairing reviewed 2026-10-27.
Where it fits
Never a substitute for your rheumatologist's treatment. Discussed for a joint or tendon that stays painful once the disease is controlled, as a way to make the exercise and hand or knee strengthening program easier to do.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Only if relevant
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
No evidence in this condition, and the rationale offered for EMTT (an effect on tendon and soft-tissue cell behaviour) does not apply to a systemic, bone or complete structural problem.
Pairing reviewed 2026-08-30.
Where it fits
Not part of the plan here.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Not offered; one open-label trial
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
Trialled once in rheumatoid arthritis, with a result that favours PRP over a single cortisone injection at six months, and not offered here. Sixty people whose rheumatoid arthritis was otherwise settled on disease-modifying medication, but who had one or two joints that stayed painful and inflamed, were given three monthly PRP injections into the joint or a single cortisone injection. Both groups had improved at three months, and the improvement was still present at six months only in the PRP group (Saif, Curr Rheumatol Rev 2021). The trial was open-label, so everyone knew which injection they had, and it came from one centre. Its published summary gives no figures for the size of the difference and the full paper could not be obtained; a later review reports that the joints were wrists, elbows and ankles and that no adverse effects were recorded over the six months (Moeda, Cureus 2022). Beyond the trial there are only handfuls of cases: four people whose joints had not settled with cortisone injections, reported as improved at four and eight weeks (Badsha, Case Rep Rheumatol 2020), and three with rheumatoid finger joints who reported 20% to 50% less pain over six months (Shively, Cureus 2021). There is also a report of the opposite: a man with rheumatoid arthritis whose knees became more swollen and painful two weeks after PRP into both, and who needed his medication increased (described in Moeda, Cureus 2022). A systematic review found a single study in people among the eight it included and called the evidence limited (Chellamuthu, Rheumatol Int 2021), and the review behind the European rheumatology recommendations on joint injections concluded that no firm conclusion can be drawn in inflammatory arthritis because the data are so limited (Rodriguez-García, RMD Open 2021). None of it alters the disease itself.
Pairing reviewed 2026-10-12.
Where it fits
Not offered here for a rheumatoid joint. Rheumatoid arthritis is controlled with disease-modifying medication under a rheumatologist, and a cortisone injection is the established choice for a joint that stays inflamed. The single PRP trial is open-label and has not been repeated. A separate tendon or joint problem in someone who has rheumatoid arthritis is assessed on that problem's own evidence.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. No study in a rheumatoid joint
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No study has tested prolotherapy as a treatment for rheumatoid arthritis or a rheumatoid joint. PubMed searches on 17 October 2026 (prolotherapy, dextrose injection, hypertonic dextrose, hyperosmolar dextrose or regenerative injection therapy with rheumatoid arthritis, synovitis or inflammatory arthritis, then randomised-trial and systematic-review passes) returned no trial or series. The nearest records are one case report of dextrose and PRP injections for neck ligament instability in a woman who also had rheumatoid arthritis, which treated the ligaments and not the disease (Jones, Cureus 2026), and a review of jaw-joint treatments in rheumatic disease that includes dextrose injected under the skin beside the nerves, a different procedure (Aiello, BMC Musculoskelet Disord 2025).
Pairing reviewed 2026-10-17.
Where it fits
Not a treatment for the inflammatory disease, which is controlled by your rheumatologist. Prolotherapy is considered only for a separate ligament or tendon problem in someone whose disease is well controlled, assessed on its own evidence.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Only if relevant
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
The overview of systematic reviews behind the 2020 EULAR recommendations on intra-articular therapy covered 29 reviews and found hyaluronic acid gives a small benefit in knee osteoarthritis but not in hip osteoarthritis or frozen shoulder, and concluded that no firm conclusion can be drawn for inflammatory arthritis because the data are so limited (Rodriguez-García, RMD Open 2021). What direct rheumatoid evidence exists sits at particular joints: in an open comparison of 70 people with a painful wrist or elbow, betamethasone alone was the most cost-effective injection while betamethasone combined with hyaluronic acid gave the best range of movement at one month (Li, J Clin Rheumatol 2018). None of this alters the disease itself.
Pairing reviewed 2026-09-12.
Where it fits
Considered only where a single joint stays painful from established joint-surface damage while the rheumatoid disease is otherwise well controlled. It is not a substitute for disease-modifying treatment, and delaying that treatment is what causes lasting damage.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Perineural dextrose evidence is concentrated in diagnosed peripheral compression neuropathies, particularly the upper limb; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis.
Evidence source: Perineural dextrose for upper-limb entrapment neuropathy review (2025)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis, perineural treatment may be considered only if a separate superficial neuropathic pain pattern is found on examination. It is not treatment of the primary diagnosis.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits
For rheumatoid arthritis, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other general conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
How is rheumatoid arthritis diagnosed?
Why does early treatment matter?
What is the GP's role?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment